Rocket Lab CEO Peter Beck has no plans to join Jeff Bezos or Richard Branson the list of space-traveling billionaires, he ...
NewAmsterdam Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Rocket Lab USA Inc (RKLB) stock saw a decline, ending the day at $22.85 which represents a decrease of $-0.39 or -1.68% from the prior close of $23.24. The stock opened at $22.85 and touched a low of ...
Total return can offer insights about a company's prospects and long-term earnings growth potential. The S&P 500 is up over ...
Archer Aviation stock has outperformed the S&P 500 over the past six months. The company has several potential catalysts in 2025 to drive the stock higher. Growth investors shouldn't be dissuaded from ...
Wells Fargo analyst Sarah Akers maintained a Hold rating on Rocket Lab USA (RKLB – Research Report) today and set a price target of $22.00. The ...
Rocket Lab's Peter Beck views paranoia as a leadership asset but experts caution about burnout risks, urging balance in ...